Document is current
Any future updates will be listed below
-
Authors
Wang, Jiemin
Moosavizadeh, Seyedmohammad
Jammes, Manon
Tabasi, Abbas
Bach, Trung
Ryan, Aideen E.
Ritter, Thomas https://orcid.org/0000-0001-7709-8489
-
Funding
Funding for this research was provided by:
China Scholarship Council (202006370067)
Horizon 2020 Framework Programme (101080611)
Research Ireland (18/EPSRC-CDT/3583, 13/RC/2073_P2, 19/FFP/6446)
- License Information
-
More Information
Article History
Received: 14 April 2025
Accepted: 18 June 2025
First Online: 9 July 2025
Declarations
:
: Peripheral blood mononuclear cells (PBMCs) were isolated from healthy donors under a research protocol titled “Isolation of PBMCs from healthy donors”, which was approved by the Clinical Research Ethics Committee at University Hospital Galway (Approval number: Ref. C.A. 2534, Date of approval: November 2020). Additionally, human bone marrow-derived mesenchymal stromal cells (MSCs) were obtained under a separate project titled “Isolation of human bone marrow-derived mesenchymal stromal cells”, approved by the Clinical Research Ethics Committee of Galway University Hospital (Approval number: Ref. 08/May/14, Date of approval: May, 2014).The THP-1 cell line was kindly provided by Dr. Aideen Ryan’s laboratory and was originally purchased from the American Type Culture Collection (ATCC, Catalog No. TIB-202). THP-1 cells were established by ATCC from a human donor with appropriate Institutional Review Board (IRB) approval and informed consent procedures in place.
: Not applicable.
: The authors declared no conflicts of interest.
